Scientists are on the verge of creating a new generation of light-activated cancer treatments, more effective than the latest immunotherapies. In this episode, we will learn all about light-activated cancer treatments.
But first, please like the video and subscribe to our channel for more such content in the future. Push the bell icon to receive updates every time we upload a video.
Scientists and researchers at the University of East Anglia are excited about treating cancer in a way that is more effective than medications available today.
Sounds exciting, doesn’t it? Let’s get straight to the point.
What is light-activated cancer treatment?
The avant-garde-sounding name will actually work by switching on LED lights.
Once the LED lights, placed close to the tumor, are switched on, the process of dispensing bio-therapeutic drugs begins. While current state-of-the-art immunotherapies brag about being the best at treating cancer, their light-activated counterpart is the next level in attacking and terminating cancerous cells.
An article published on Science Daily reveals the secret behind the innovative idea. The team at the University of East Anglia (UEA) engineered fragments of antibodies to fuse with the target. The light-activated antibodies can precisely attack cancerous cells.
Dr. Amit Sachdeva, the brain behind the study, revealed that traditional treatments damage healthy cells along with killing cancer cells; however, the light-activated cancer treatment will prove to be a game changer.
Dr. Sachdeva said, “We hope that our work will lead to the development of a new class of highly targeted light-responsive biotherapeutics. This would mean that antibodies could be activated at the site of a tumour and covalently stick to their target upon light activation.”
“This would allow cancer treatment to be more efficient and targeted because it means that only molecules in the vicinity of the tumour would be activated, and it wouldn’t affect other cells,” he further stated.
According to Doctor Sachdeva, the new treatment would reduce the chances of side effects by a great degree and “improve the antibody residence time in the body.” As per the lead scientist, the new treatment would work for solid tumors and skin cancer but not against Leukemia or other blood cancer types.
The Science Daily article mentions:
“If the researchers are successful in the next stages of their work, they hope to see the ‘next generation’ light-activated immunotherapies being used to treat cancer patients within five to 10 years.”
How did you find this information? Please mention this in the comments section. We would also like to know the kind of content you want to watch, and we will try to create it for you. For more news and updates, follow Airr News.
#LighActvatedCancerTreatment #Tumour #CancerSurvival #CancerFree #Chemotherap #CancerMaintenanceTherapy #ClinicalTrials #SkinCancer #BioTherapeuticDrugs #Immunotherapy #AmitSachdeva #UniversityOfEastAnglia #Scientists #CancerResearchers #LEDLights
